Author(s): Naim Uddin and OP Rai

Abstract: This research paper examines the impact of patent law on generic pharmaceuticals in India, focusing on the historical evolution from the Patents Act of 1970 to the amendments introduced in 2005. It explores key concepts such as patents, generic drugs, and compulsory licensing, highlighting their implications for public health and access to essential medicines. The paper analyzes the challenges faced by generic pharmaceutical manufacturers in navigating the patent landscape and the role of compulsory licensing in enhancing drug accessibility during public health emergencies. Additionally, it discusses the broader public health implications of patent law, including its effect on disease burden and economic considerations within the healthcare system. Finally, the paper offers policy recommendations aimed at strengthening the link between patent law and public health, emphasizing the need for a balanced approach that prioritizes both innovation and accessibility. Through this analysis, the study aims to contribute to the ongoing discourse on intellectual property rights and their implications for healthcare in India.

Pages: 134-140 | Views: 134 | Downloads: 97

Download Full Article: Click Here